| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $7.44 ▼ -3.88% | Yesterday | $7.73 ▲ +0.13% | Tomorrow's Unicycive Therapeutics Inc. Common Stock (UNCY) setup is anchored to $7.74 and targets $7.44 (-3.88%). The near-term read is downside; watch $7.97 / $7.05 because daily realized volatility is about 3.13%. |
Tomorrow's Unicycive Therapeutics Inc. Common Stock (UNCY) setup is anchored to $7.74 and targets $7.44 (-3.88%). The near-term read is downside; watch $7.97 / $7.05 because daily realized volatility is about 3.13%. | ||||
| Week | $7.50 ▼ -3.10% | Last Week | $8.56 ▼ -9.58% | The 7-day Unicycive Therapeutics Inc. Common Stock model moves from $8.56 to $7.50 (-3.10%). It gives downside momentum context for this stock, so breaks around $7.97 / $7.05 matter more than a single tick. |
The 7-day Unicycive Therapeutics Inc. Common Stock model moves from $8.56 to $7.50 (-3.10%). It gives downside momentum context for this stock, so breaks around $7.97 / $7.05 matter more than a single tick. | ||||
| Month | $7.80 ▲ +0.78% | Last Month | $7.21 ▲ +7.35% | The 1-month Unicycive Therapeutics Inc. Common Stock target is $7.80 (+0.78%), compared with the live reference near $7.74. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Unicycive Therapeutics Inc. Common Stock target is $7.80 (+0.78%), compared with the live reference near $7.74. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $8.26 ▲ +6.72% | Last Year | $5.70 ▲ +35.79% | The 1-year Unicycive Therapeutics Inc. Common Stock scenario points to $8.26 (+6.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Unicycive Therapeutics Inc. Common Stock scenario points to $8.26 (+6.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $9.31 ▲ +20.28% | 5 Years Ago | $58.50 ▼ -86.77% | The 5-year Unicycive Therapeutics Inc. Common Stock view is $9.31 (+20.28%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Unicycive Therapeutics Inc. Common Stock view is $9.31 (+20.28%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 5.0 | Bearish |
| MACD | -0.09 | Bearish |
| SMA 50 | $7.82 | Below |
| SMA 200 | $13.15 | Below |
| EMA 20 | $16.14 | Below |
| Opening Price | $7.88 | Start Date | 2021-07-13 |
| Day Range | $7.62 – $7.97 | Market Cap | $181.96M |
| Monthly Range | $6.62 – $8.56 | 24h Volume | n/a |
| 90D Range | $5.87 – $8.56 | Circulating | n/a |
| 52W Range | $3.74 – $9.00 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.